Posted by Michael Wonder on 16 Sep 2019
EMA publishes agenda for 16-19 September CHMP meeting
13 September 2019 - The EMA has published a draft agenda for this week's CHMP meeting.
The CHMP is due to issue initial opinions for the following technologies:
- Arsenic trioxide
- Bortezomib
- Clofarabine
- Polatuzumab vedotin
- Dapagliflozin propanediol monohydrate with saxagliptin hydrochloride and metformin hydrochloride
- Lignocaine with prilocaine
